Local Coverage With Evidence Development Is Legit, CMS Says; But It May Be Rare
This article was originally published in The Gray Sheet
Executive Summary
CMS issued its final guidance on the coverage-with-evidence-development program, two years following a draft. It is explicit that local Medicare contractors can employ CED in setting coverage policies in their jurisdictions, but it is not clear that the language will encourage significant use at the local level. The guidance also revises its approach on ending CED policies compared to what was stated in the 2012 draft guidance.
You may also be interested in...
Medicare 'Coverage With Evidence' May Rise With FDA Postmarket Emphasis
As FDA touts plans to shift clinical data requirements when possible to the postmarket phase, a top CMS official highlights the importance of the Medicare coverage with evidence development policy.
Paying For Placebo Is ‘Biggest Change’ In Medicare CED Policy, Official Says
The director of Medicare’s coverage group sees the ability to pay physicians for providing a placebo or sham control in studies required under a coverage-with-evidence-development determination as a major improvement included in the agency's its recent guidance for CED.
Louis Jacques On Coverage, Evidence And IDEs
In the first part of a two-part Q&A, just-departed CMS coverage director Louis Jacques talks about the strong future ahead he envisions for the Medicare coverage-with-evidence-development program and new coverage policies that will be implemented for investigational device exemption trials.